Takeda Pharmaceutical Company Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was JPY 1,096,600 million compared to JPY 901,300 million a year ago. Net income was JPY 119,100 million compared to JPY 57,800 million a year ago. Basic earnings per share from continuing operations was JPY 76.63 compared to JPY 36.91 a year ago.
For the nine months, sales was JPY 3,071,322 million compared to JPY 2,695,717 million a year ago. Net income was JPY 285,883 million compared to JPY 241,417 million a year ago. Basic earnings per share from continuing operations was JPY 184.32 compared to JPY 154.09 a year ago. Diluted earnings per share from continuing operations was JPY 182.65 compared to JPY 153.03 a year ago.